← All trials
NCT05167448
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 25, 2022
- Primary completion
- May 31, 2026
- Completion date
- Jul 31, 2026
- First posted
- Dec 22, 2021
- Last posted
- Mar 23, 2022
- Enrollment
- 58
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Elpiscience (Suzhou) Biopharma, Ltd.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.